(Q43060441)

13 November 2017

Food significantly reduces plasma concentrations of first-line anti-tuberculosis drugs (English)

1 reference

13 November 2017

6

Soumya Swaminathan

0 references

author name string

Agibothu Kupparam Hemanth Kumar

1

1 reference

13 November 2017

Vedachalam Chandrasekaran

2

1 reference

13 November 2017

Angadi Kiran Kumar

3

1 reference

13 November 2017

M Kawaskar

4

1 reference

13 November 2017

J Lavanya

5

1 reference

13 November 2017

Geetha Ramachandran

7

1 reference

13 November 2017

language of work or name

English

0 references

publication date

1 April 2017

1 reference

Indian Journal of Medical Research

13 November 2017

1 reference

13 November 2017

145

1 reference

13 November 2017

4

1 reference

13 November 2017

530-535

1 reference

Factors Influencing Tuberculosis Treatment Outcome in Adult Patients Treated with Thrice-Weekly Regimens in India

13 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5663168

Effects of dosage, comorbidities, and food on isoniazid pharmacokinetics in Peruvian tuberculosis patients

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5663168

Serum drug concentrations predictive of pulmonary tuberculosis outcomes

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5663168

Impact of food and antacids on the pharmacokinetics of anti-tuberculosis drugs: systematic review and meta-analysis.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5663168

Therapeutic drug monitoring in the treatment of tuberculosis

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5663168

Pharmacokinetics of isoniazid under fasting conditions, with food, and with antacids

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5663168

Pharmacokinetics of ethambutol under fasting conditions, with food, and with antacids

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5663168

Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5663168

Pharmacokinetics of pyrazinamide under fasting conditions, with food, and with antacids.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5663168

Study of the effect of concomitant food on the bioavailability of rifampicin, isoniazid and pyrazinamide

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5663168

Influence of Food on the Bioavailability of Drugs

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5663168

Impact of food intake on the pharmacokinetics of first-line antituberculosis drugs in Taiwanese tuberculosis patients.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5663168

Ofloxacin population pharmacokinetics in patients with tuberculosis.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5663168

Effect of food on bioavailability of rifampicin.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5663168

In vitro evaluation of food effect on the bioavailability of rifampicin from antituberculosis fixed dose combination formulations

15 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28862186

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pharmacokinetic/pharmacodynamic parameters and the choice of high-dosage rifamycins

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28862186

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

1 reference

13 November 2017

PubMed publication ID

28862186

1 reference